Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Eichinger

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Annals of the American Thoracic Society|August 22, 2024
Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2-5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2, Open-Label Clinical TrialMirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society|January 11, 2024
Magnetic Resonance Imaging of Pulmonary and Paranasal Sinus Abnormalities in Children with Primary Ciliary Dyskinesia Compared to Children with Cystic FibrosisLena Wucherpfennig, Felix Wuennemann, Monika Eichinger, et al.
European Radiology|September 23, 2021
Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary functionMarilisa Schiwek, Simon M F Triphan, Jürgen Biederer, et al.
European Radiology|April 13, 2025
Longitudinal MRI in comparison to low-dose CT for follow-up of incidental pulmonary nodules in patients with COPD-a nationwide multicenter trialLin Zhu, Qian Li, Oyunbileg von Stackelberg, et al.
Scientific Reports|April 5, 2025
Sex-specific aspects in a population of patients undergoing evaluation for interstitial lung disease with transbronchial cryobiopsyJanna Reinhard, Markus Polke, Katharina Buschulte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2024
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorLena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, et al.
Annals of the American Thoracic Society|March 21, 2023
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2 Placebo-controlled Clinical TrialMirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society|September 10, 2024
Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis From Infancy through AdolescenceMark O Wielpütz, Mirjam Stahl, Simon M F Triphan, et al.
ERJ Open Research|April 3, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosisPatricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2018
Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosisMark O Wielpütz, Oyunbileg von Stackelberg, Mirjam Stahl, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Annals of the American Thoracic Society|August 22, 2024
Long-Term Impact of Lumacaftor/Ivacaftor Treatment on Cystic Fibrosis Disease Progression in Children 2-5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2, Open-Label Clinical TrialMirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society|January 11, 2024
Magnetic Resonance Imaging of Pulmonary and Paranasal Sinus Abnormalities in Children with Primary Ciliary Dyskinesia Compared to Children with Cystic FibrosisLena Wucherpfennig, Felix Wuennemann, Monika Eichinger, et al.
European Radiology|September 23, 2021
Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary functionMarilisa Schiwek, Simon M F Triphan, Jürgen Biederer, et al.
European Radiology|April 13, 2025
Longitudinal MRI in comparison to low-dose CT for follow-up of incidental pulmonary nodules in patients with COPD-a nationwide multicenter trialLin Zhu, Qian Li, Oyunbileg von Stackelberg, et al.
Scientific Reports|April 5, 2025
Sex-specific aspects in a population of patients undergoing evaluation for interstitial lung disease with transbronchial cryobiopsyJanna Reinhard, Markus Polke, Katharina Buschulte, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 13, 2024
Elexacaftor/tezacaftor/ivacaftor improves chronic rhinosinusitis detected by magnetic resonance imaging in children with cystic fibrosis on long-term therapy with lumacaftor/ivacaftorLena Wucherpfennig, Johanna K Z Becker, Felix Wuennemann, et al.
Annals of the American Thoracic Society|March 21, 2023
Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for <i>F508del-CFTR</i>: A Phase 2 Placebo-controlled Clinical TrialMirjam Stahl, Jobst Roehmel, Monika Eichinger, et al.
Annals of the American Thoracic Society|September 10, 2024
Longitudinal Magnetic Resonance Imaging of Changes in Lung Morphology and Perfusion in Children with Cystic Fibrosis From Infancy through AdolescenceMark O Wielpütz, Mirjam Stahl, Simon M F Triphan, et al.
ERJ Open Research|April 3, 2023
Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosisPatricia Leutz-Schmidt, Daiva-Elzbieta Optazaite, Olaf Sommerburg, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2018
Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosisMark O Wielpütz, Oyunbileg von Stackelberg, Mirjam Stahl, et al.
Pageof 10